Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines

Erythropoiesis-stimulating agents (ESA) are used commonly to reduce symptomatic anemia in patients with myelodysplastic syndromes (MDS).We assessed population-based patterns of ESA use relative to treatment guidelines using data from the Surveillance, Epidemiology, and End Results (SEER) registries,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Davidoff, Amy J., Weiss, Sheila R., Baer, Maria R., Ke, Xuehua, Hendrick, Franklin, Zeidan, Amer, Gore, Steven D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694576/
https://ncbi.nlm.nih.gov/pubmed/23523473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2013.02.021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky